Info

MC Heinrich, KV Silvey, S Stone, AJ Zigler, DJ Griffith, M Montalto, L Chai, Y Zhi, ME Hoatlin. Post-transcriptional cell cycle-dependent regulation of human FANCC expression. Blood 95:3970-3977, 2000.

H Youssoufian. Cytoplasmic localization of FAC is essential for the correction of a prerepair defect in Fanconi anemia group C cells. J Clin Invest 97:2003-2010, 1996. T Reuter, S Herterich, O Bernhard, H Hoehn, HJ Gross. Strong FANCA/FANCG but weak FANCA/FANCC interaction in the yeast two hybrid system. Blood 95:719-720, 2000.

AL Medhurst, PA Huber, Q Waisfisz, JP de Winter, CG Mathew. Direct interactions of the five known Fanconi anaemia proteins suggest a common functional pathway. Hum Mol Genet 10:423-429, 2001.

TM Schroeder-Kurth, AD Auerbach, G Obe, eds. Fanconi Anemia. Clinical, Cytogenetic and Experimental Aspects. Berlin: Springer-Verlag, 1989. K Motejlek, D Schindler, G Assum, W Krone. Increased amount and contour length distribution of small polydisperse circular DNA (spcDNA) in Fanconi anemia. Mut Res DNA Repair 293:205-214, 1993.

LH Thompson, D Schild. Homologous recombinational repair of DNA ensures mammalian chromosome stability. Mutat Res 477:131-153, 2001. MW Lambert, GJ Tsongalis, WC Lambert, B Hang, DD Parrish. Defective DNA en-donuclease activities in Fanconi 's anemia cells, complementation groups A and B. Mutat Res 273:57-71, 1992.

A Laquerbe, E Moustacchi, JC Fuscoe, D Papdopoulo. The molecular mechanism underlying formation of deletions in Fanconi anemia cells may involve a site-specific recombination. Proc Natl Acad Sci USA 92:831-885, 1995. D Averbeck, D Papadopoulo, E Moustacchi. Repair of 4,5'8-trimethylpsoralen plus light-induced DNA damage in normal and Fanconi's anemia cell lines. Cancer Res 48:2015-2020, 1988.

J Smith, JC Andrau, S Kallenbach, A Laguerbe, N Doyen, D Papadopoulo. Abnormal rearrangements associated with V(D)J recombination in Fanconi anemia. J Mol Biol 281:815-825, 1998.

R Lundberg, M Mavinakere, C Campell. Deficient DNA end joining activity in extracts from Fanconi anemia fibroblasts. J Biol Chem 279:9543-9549, 2001. JP Carney, RS Maser, H Olivares, EM Davis, M Le Beau, JR Yates 3rd, L Hays, WF Morgan, JH Petrini. The hMre11/Rad50 protein complex and Nijmegen breakage syndrome: linkage of double-strand break repair to the cellular DNA damage response. Cell 93:477-486, 1998.

E Raderschall, EI Golub, T Haaf. Nuclear foci of mammalian recombination proteins are located at single-stranded DNA regions formed after DNA damage. Proc Natl Acad Sci USA 96:1921-1926, 1999.

S Tashiro, J Walter, A Shinohara, N Kamada, T Cremer. Rad51 accumulation at sites of DNA damage in postreplicative chromatin. J Cell Biol 150:283-291, 2000. Y Liu, N Maizels. Coordinated response of mammalian Rad51 and Rad52 to DNA damage. EMBO Rep 1:85-90, 2000.

M Takata, MS Sasaki, S Tachiiri, T Fukushima, E Sonoda, D Schild, LH Thompson, S Takeda. Chromosome instability and defective recombinational repair in knockout mutants of the five Rad51 paralogs. Mol Cell Biol 21:2858-2866, 2001. RC Cumming, JM Liu, H Youssoufian, M Buchwald. Suppression of apoptosis in hematopoietic factor-dependent progenitor cell lines by expression of the FAC gene. Blood 88:4558-4567, 1996.

A Ridet, C Guillof, E Duchaud, E Cundari, M Fiore, E Moustacchi, F Rosselli. Deregulated apoptosis is a hallmark of the Fanconi anemia syndrome. Cancer Res 57:1722-1730, 1997.

C Guillof, TS Wang, J Liu, CE Walsh, GG Poirier, E Moustacchi, F Rosselli. Fanconi anemia C protein acts as switch between apoptosis and necrosis in mitomycin C-induced cell death. Exp Cell Res 246:384-394, 1999.

T Haaf, E Raderschall, G Reddy, DC Ward, CM Radding, EI Golub. Sequestration of mammalian Rad51-recombination protein into micronuclei. J Cell Biol 144:11-20, 1999.

KW Kinzler, B Vogelstein. Gatekeepers and caretakers. Nature 386:761-763, 1997. TM Schroeder, F Anschutz, A Knopp. Spontane Chromosomenaberrationen bei fa-miliarer Panmyelopathie. Humangenetik 1:194-196, 1964.

AD Auerbach. Fanconi anemia diagnosis and the diepoxybutane (DEB) test. Exp Hematol 21:731-733, 1993.

M Carreau, N Alon, L Bosnoyan-Collins, H Joenje, M Buchwald. Drug sensitivity spectra in Fanconi anemia lymphoblastoid cell lines of defined complementation groups. Mutat Res 435:103-109, 1999.

CS Djuzenova, A Rothfuss, U Oppitz, G Speit, D Schindler, H Hoehn, M Flentje. Response to X-irradiation of Fanconi anemia homozygous and heterozygous cells assessed by the single-cell gel electrophoresis (comet) assay. Lab Invest 81:185-192, 2001.

T Reuter, S Herterich, H Hoehn, HJ Gross. Search for proteins involved in the pathogenesis of Fanconi anemia. Am J Hum Genet 61:A181, 1997. T Reuter. Die Fanconi Proteine: Ein Beitrag zur Aufklärung ihrer Funktion. PhD dissertation, University of Wuerzburg, Wuerzburg, Germany, 2000. TT Paull, EP Rogakou, V Yamazaki, CU Kirchgessner, M Gellert, WM Bonner. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr Biol 10:886-895, 2000.

JR Davie, M Moniwa. Control of chromatin remodeling. Crit Rev Eukaryot Gene Expr 10:303-325, 2000.

DA Bochar, L Wang, H Beniya, A Kinev, Y Xue, WS Lane, W Wang, F Kashanchi, R Shiekhattar. BRCA1 is associated with a human SWI/SNF-related complex: linking chromatin remodeling to breast cancer. Cell 102:257-265, 2000. ME Hoatlin, Y Zhi, H Ball, K Silvey, A Melnick, S Stone, S Arai, N Hawe, G Owen, A Zelent, JD Licht. A novel BTB/POZ transcriptional repressor protein interacts with the Fanconi anemia group C protein and PLZF. Blood 94:3737-3747, 1999. PH Gaillard, EM Martini, PD Kaufman, B Stillman, E Moustacchi, G Almouzni. Chromatin assembly coupled to DNA repair: a new role for chromatin assembly factor I. Cell 86:887-896, 1996.

F Qiao, A Moss, GM Kupfer. Fanconi anemia proteins localize to chromatin and the nuclear matrix in a DNA damage and cell cycle-regulated manner. J Biol Chem 276:23391-23396, 2001.

Y Xie, JP de Winter, Q Waisfisz, AW Nieuweint, RJ Scheper, F Arwert, ME Hoatlin, GJ Ossenkoppele, GJ Schuurhuis, H Joenje. Aberrant Fanconi anaemia protein profiles in acute myeloid leukaemia cells. Br J Haematol 111:1057-1064, 2000.

JR Lo Ten Foe, ML Kwee, MA Rooimans, AB Oostra, AJP Veerman, M van Weel, RM Pauli, NT Shahidi, I Dokal, I Roberts, C Altay, E Gluckman, RA Gibson, CG Mathew, F Arwert, H Joenje. Somatic mosaicism in Fanconi anemia: molecular basis and clinical significance. Eur J Hum Genet 5:137-148, 1997. H Joenje, F Arwert, ML Kwee, K Madan, H Hoehn. Confounding factors in the diagnosis of Fanconi anaemia. Am J Med Genet 79:403-405, 1998. JJ Gregory Jr, JE Wagner, PC Verlander, O Levran, SD Batish, CR Eide, A Steffenhagen, B Hirsch, AD Auerbach. Somatic mosaicism in Fanconi anemia: evidence of genotypic reversion in lymphohematopoietic stem cells. Proc Natl Acad Sci USA 98:2532-2537, 2001.

O Levran, T Erlich, N Magdalena, J Gregory, S Batish, P Verlander, A Auerbach. Sequence variation in the Fanconi anemia gene FAA. Proc Natl Acad Sci USA 94:13051-13056, 1997.

NV Morgan, AJ Tipping, H Joenje, CG Mathew. High frequency of large intragenic deletions in the Fanconi group A gene. Am J Hum Genet 65:1330-1341, 1999. Q Waisfisz, NV Morgan, M Savino, JP de Winter, CG van Berkel, ME Hoatlin, L Ianzano, RA Gibson, F Arwert, A Savoia, CG Mathew, JC Pronk, H Joenje. Spontaneous functional correction of homozygous Fanconi anaemia alleles reveals novel mechanistic basis for reverse mosaicism. Nat Genet 22:379-383, 1999. R Berger, P Jonveaux. Clonal chromosome abnormalities in Fanconi anemia. Hema-tol Cell Ther 38:291-296, 1996.

BP Alter, A Scalise, J McCombs, V Najfeld. Clonal chromosomal abnormalities in Fanconi's anaemia: what do they really mean? Br J Haematol 85:627-630, 1993. BP Alter, JP Caruso, RA Drachtman, T Uchida, GV Velagaleti, MT Elghetany. Fan-coni anemia: myelodysplasia as a predictor of outcome. Cancer Genet Cytogenet 117:125-131, 2000.

MT Smith, L Zhang, M Jeng, Y Wang, W Guo, P Duramad, AE Hubbard, G Hofstadler, NT Holland. Hydrochinone, a benzene metabolite, increases the level of aneusomy of chromosomes 7 and 8 in human CD34-positive blood progenitor cells. Carcinogenesis 21:1485-1490, 2000.

TA McDonald, NT Holland, C Skibola, P Duramad, MT Smith. Hypothesis: phenol and hydroquinone derived mainly from diet and gastrointestinal flora activity are causal factors in leukemia. Leukemia 15:10-20, 2001.

F Leteutre, X Li, P Guardiola, G Le Roux, JC Sergere, P Richard, ED Carosella, E Gluckman. Accelerated telomere shortening and telomerase activation in Fanconi's anaemia. Br J Haematol 105:883-893, 1999.

SE Ball, FM Gibson, S Rizzo, JA Tooze, JC Marsh, EC Gordon-Smith. Progressive telomere shortening in aplastic anemia. Blood 91:3582-3592, 1998. GM Martin, CA Sprague, TH Norwood, WR Pendergrass. Clonal selection, attenuation and differentiation in an in vitro model of hyperplasia. Am J Pathol 74:137-154, 1974.

C Lengauer, KW Kinzler, B Vogelstein. Genetic instabilities in human cancers. Nature 396:643-649, 1998.

M Lensch, R Rathbun, S Olson, GR Jones, GC Bagby Jr. Selective pressure as an essential force in molecular evolution of myeloid leukemic clones: a view from the window of Fanconi anemia. Leukemia 13:1784-1789, 1999

E Elmore, M Swift. Growth of cultured cells from patients with Fanconi anemia. J Cell Physiol 87:229-233, 1975.

R Weksberg, M Buchwald, P Sargent, MW Thompson, L Siminovitch. Specific cellular defects in patients with Fanconi anemia. J Cell Physiol 101:311-323, 1979. B Dutrillaux, A Aurias, AM Dutrillaux, D Buriot, M Prieur. The cell cycle of lymphocytes in Fanconi anemia. Hum Genet 62:327-332, 1982. M Kubbies, D Schindler, H Hoehn, A Schinzel, PS Rabinovitch. Endogenous blockage and delay of the chromosome cycle despite normal recruitment and growth phase explain poor proliferation and frequent endomitosis in Fanconi anemia cells. Am J Hum Genet 37:1022-1030, 1985.

R Berger, M Le Coniat, MC Gendron. Fanconi anemia. Chromosome breakage and cell cycle studies. Cancer Genet Cytogenet 69:13-16, 1993. H Seyschab, R Friedl, Y Sun, D Schindler, H Hoehn, S Hentze, T Schroeder-Kurth. Comparative evaluation of diepoxybutane sensitivity and cell cycle blockage in the diagnosis of Fanconi anemia. Blood 85:2233-2237, 1995.

FA Kruyt, LM Dijkmans, F Arwert, H Joenje. Involvement of the Fanconi's anemia protein FAC in a pathway that signals to the cyclin B/cdc2 kinase. Cancer Res 57:2244-2251, 1997.

GM Kupfer, T Yamashita, D Naf, A Suliman, S Asano, AD D'Andrea. The Fanconi anemia polypeptide, FAC, binds to the cyclin-dependent kinase cdc2. Blood 90:1047-1054, 1997.

SA Centurion, HR Kuo, WC Lambert. Damage-resistant DNA synthesis in Fanconi anemia cells treated with a DNA cross-linking agent. Exp Cell Res 260:216-221, 2000. M Sala-Trepat, D Rouillard, M Escarceller, A Laquerbe, E Moustacchi, D Pa-padopoulo. Arrest of S-phase progression is impaired in Fanconi anemia cells. Exp Cell Res 260:208-215, 2000

L Sabatier, B Dutrillaux. Effect of caffeine in Fanconi anemia. I. Restoration of a normal duration of G2 phase. Hum Genet 79:242-244, 1988. H Seyschab, G Bretzel, R Friedl, D Schindler, Y Sun, H Hoehn. Modulation of the spontaneous G2 phase blockage in Fanconi anemia cells by caffeine: differences to cells arrested by X-irradiation. Mutat Res 308:149-157, 1994. P Johnstone, C Reifsteck, S Kohler, P Worland, S Olson, RE Moses. Fanconi anemia group A and D cell lines respond normally to inhibitors of cell cycle regulation. Somat Cell Mol Genet 23:371-377, 1997.

MC Heinrich, ME Hoatlin, AJ Zigler, KV Silvey, AC Bakke, WW Keeble, Y Zhi, CA Reifsteck, M Grompe, MG Brown, RE Magenis, SB Olson, GC Bagby. DNA cross-linker-induced G2/M arrest in group C Fanconi anemia lymphoblasts reflects normal checkpoint function. Blood 91:275-287, 1998.

GM Martin, SN Austad, TE Johnson. Genetic analysis of ageing: role of oxidative damage and environmental stresses. Nat Genet 13:25-34, 1996. R Perez-Campo, M Lopes-Torres, S Cadenas, C Rojas, G Barja. The rate of free radical production as a determinant of the rate of aging: evidence from the comparative approach. J Comp Physiol (B) 168:149-158, 1998.

A Herrero, G Barja. 8-oxo-deoxyguanosine levels in heart and brain mitochondrial and nuclear DNA of two mammals and three birds in relation to their different rates of aging. Aging (Milano) 11:294-300, 1999.

H Joenje, F Arwert, AW Eriksson, H de Koning, AB Oostra. Oxygen-dependence of chromosomal aberrations in Fanconi's anemia. Nature 290:142-143, 1981. D Schindler, H Hoehn. Fanconi anemia mutation causes cellular susceptibility to ambient oxygen. Am J Hum Genet 43:429-435, 1988.

H Saito, AT Hammond, RE Moses. Hypersensitivity to oxygen is a uniform and secondary defect in Fanconi anemia cells. Mutat Res 294:255-262, 1993. H Saito, AT Hammond, RE Moses. The effect of low oxygen tension on the in vitro replicative lifespan of human diploid fibroblast cells and their transformed derivatives. Exp Cell Res 217:272-279, 1995.

M Poot, O Gross, B Epe, M Pflaum, H Hoehn. Cell cycle defect in connection with oxygen and iron sensitivity in Fanconi anemia lymphoblastoid cells. Exp Cell Res 222:262-268, 1996

H Maeda, T Hotta, H Yamada. Enhanced colony formation of human hematopoietic stem cells in reduced oxygen tension. Exp Hematol 14:930-934, 1986. AP Alter, ME Knobloch, RS Weinberg. Erythropoiesis in Fanconi's anemia. Blood 78:602-608, 1991.

G Pagano, LG Korkina. Prospects for nutritional intervention in the clinical management of Fanconi anemia. Cancer Causes Control 11:881-889, 2000. G Pagano, LG Korkina, P Degan, D Del Principe, B Lindau-Shepard, A Zatterale, C Franceschi. In vitro hypersensitivity to oxygen of Fanconi anemia (FA) cells is linked to ex vivo evidence for oxidative stress in FA homozygotes and heterozygotes. Blood 89:1111-1112, 1997.

W Ruppitsch, C Meisslitzer, M Hirsch-Kauffmann, M Schweiger. Overexpression of thioredoxin in Fanconi anemia fibroblasts prevents the cytotoxic and DNA damaging effect of mitomycin C and diepoxybutane. FEBS Lett 422:99-102, 1998. D Lackinger, W Ruppitsch, MH Ramirez, M Hirsch-Kauffmann, M Schweiger. Involvement of the Fanconi anemia protein FA-C in repair processes of oxidative DNA damages. FEBS Lett 440:103-106, 1998.

W Liebetrau, TM Runger, BE Mehling, M Poot, H Hoehn. Mutagenic activity of ambient oxygen and mitomycin C in Fanconi's anaemia cells. Mutagenesis 12: 69-77, 1997.

MR Kelley, R Tritt, Y Xu, S New, B Freie, DW Clapp, WA Deutsch. The Drosophila S3 multifunctional DNA repair/ribosomal protein protects Fanconi anemia cells against oxidative DNA damaging agents. Mutat Res 485:107-119, 2001. J Pincheira, M Bravo, MJ Santos, C de la Torre, JF Lopez-Saez. Fanconi anemia lymphocytes: effect of DL-alpha-tocopherol (vitamin E) on chromatid breaks and on G2 repair efficiency. Mutat Res 461:265-271, 2001.

DT Bowen. Oxidative stress and the myelodysplastic syndromes. Leuk Res 24:139-140, 2000.

R Notaro, N Montuori, C di Grazia, S Formisano, B Rotoli, C Selleri. Fanconi's anemia cells are relatively resistant to H2O2-induced damage. Haematologica 83:868-874, 1998.

AA Clarke, NJ Philpott, EC Gordon-Smith, TR Rutherford. The sensitivity of Fan-coni anaemia group C cells to apoptosis induced by mitomycin C is due to oxygen radical generation, not DNA crosslinking. Br J Haematol 96:240-247, 1997.

135. G Pagano. Mitomycin C and diepoxybutane action mechanisms and FANCC protein functions: further insights into the role for oxidative stress in Fanconi's anaemia phenotype. Carcinogenesis 21:1067-1068, 2000.

136. P Degan, S Bonassi, M De Caterina, LG Korkina, L Pinto, F Scopacasa, A Zatterale, R Calzone, G Pagano. In vivo accumulation of 8-hydroxy-2'-deoxyguanosine in DNA correlates with release of reactive oxygen species in Fanconi's anaemia families. Carcinogenesis 16:735-741, 1995.

137. A Zunino, P Degan, T Vigo, A Abbondandolo. Hydrogen peroxide: effects on DNA, chromosomes, cell cycle and apoptosis induction in Fanconi's anemia cell lines. Mutagenesis 16:283-238, 2001.

138. O Will, D Schindler, S Boiteux, B Epe. Fanconi's anaemia cells have normal steady-state levels and repair of oxidative DNA base modifications sensitive to Fpg protein. Mutat Res 409:65-72, 1998.

139. DS Seres, AC Fornace Jr. Normal response of Fanconi's anemia cells to high concentrations of O2 as determined by alkaline elution. Biochem Biophys Acta 698:237-242, 1982.

140. H Joenje, H Youssoufian, FA Kruyt, CC dos Santos, R Wevrick, M Buchwald. Expression of the Fanconi anemia gene FAC in human cell lines: lack of effect of oxygen tension. Blood Cells Mol Dis 21:182-191, 1995.

141. PA Tower, TA Christianson, ST Peters, ML Ostroski, ME Hoatlin, AJ Zigler, MC Heinrich, RK Rathbun, W Keeble, GR Faulkner, GC Bagby Jr. Expression of the Fanconi anemia group C gene in hematopoietic cells is not influenced by oxidative stress, cross-linking agents, radiation, heat, or mitotic inhibitory factors. Exp Hematol 26:19-26, 1998.

142. Y Wang, D Cortez, P Yazdi, N Neff, SJ Elledge, J Qin. BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev 14:927-939, 2000.

143. F Le Page, V Randrianarison, D Marot, J Cabannes, M Perricaudet, J Feunteun, A Sarasin. BRCA1 and BRCA2 are necessary for the transcription-coupled repair of the oxidative 8-oxoguanine lesion in human cells. Cancer Res 60:5548-5552, 2000.

144. LC Gowen, AV Avrutskaya, AM Latour, BH Koller, SA Leadon. BRCA1 required for transcription-coupled repair of oxidative DNA damage. Science 281:10091012, 1998.

145. JJP Gille, HM Wortelboer, H Joenje. Antioxidant status of Fanconi anemia fibroblasts. Hum Genet 77:28-31, 1987.

146. S Hadjur, K Ung, L Wadsworth, J Dimmick, E Rajcan-Separovic, RW Scott, M Buchwald, FR Jirik. Defective hematopoiesis and hepatic steatosis in mice with combined deficiencies of the genes encoding Fancc and Cu/Zn superoxide dismu-tase. Blood 98:1003-1011, 2001.

147. E Gluckman. Allogeneic bone marrow transplantation in Fanconi anemia. Bone Marrow Transplant Suppl 3:S33-S35, 1996.

148. FJ Millen, MG Rainey, JM Hows, PA Burton, GH Irvine, D Swirsky. Oral squamous cell carcinoma after allogeneic bone marrow transplantation for Fanconi anaemia. Br J Haematol 99:410-414, 1997.

149. M Aker, G Varadi, S Slavin, A Nagler. Fludarabine-based protocol for human umbilical cord blood transplantation in children with Fanconi anemia. J Pediatr Hema-tol Oncol 21:237-239, 1999.

150. F Boulad, A Gillio, TN Small, D George, V Prasad, J Torok-Castanza, AD Regan, N Collins, AD Auerbach, NA Kernan, RJ O'Reilly. Stem cell transplantation for the treatment of Fanconi anaemia using a fludarabine-based cytoreductive regimen and T-cell-depleted related HLA-mismatched peripheral blood stem cell grafts. Br J Haematol 111:1153-1157, 2000.

151. D Josefson. Couple select healthy embryo to provide stem cells for sister. BMJ 321:917, 2000.

152. AD Auerbach, M Buchwald, H Joenje. Fanconi anemia. In: The Metabolic and Molecular Basis of Inherited Disease. CR Scriver, A Beaudet, W Sly, D Valle, B Childs, K Kinzler, B Vogelstein, eds. New York: McGraw-Hill, 2000, pp 753-768.

153. JM Liu, S Kim, EJ Read, M Futaki, I Dokal, CS Carter, SF Leitman, M Pensiero, NS Young, CE Walsh. Engraftment of hematopoietic progenitor cells transduced with the Fanconi anemia group C gene (FANCC). Hum Gene Ther 10:2337-2346, 1999.

154. H Youssoufian, FAE Kruyt, X Li. Protein replacement by receptor-mediated endo-cytosis corrects the sensitivity of Fanconi anemia group C cells to mitomycin C. Blood 93:363-369, 1999.

155. Y Takihara, J Hara. Polycomb-group genes and hematopoiesis. J Hematol 72:165-172, 2000.

156. GM Martin. Proliferative homeostasis and its age-related aberrations. Mech Ageing Dev 9:385-391, 1979.

157. NG Howlett, T Taniguchi, S Olson, B Cox, Q Waisfisz, C de Die-Smulders, N Per-sky, M Grompe, H Joenje, G Pals, H Ikeda, EA Fox, AD D'Andrea. Biallelic Inac-tivation of BRCA2 in Fanconi Anemia. Science, 297:606-609, 2002.

158. M Escarcellar, S Rousset, D Papadopolou. The fidelity of double strand break processing is impaired in complementation groups B and D of Fanconi anemia, a genetic instability syndrome. Somat Cell Mol Genet 23:401-11, 1997

159. T Taniguchi, I Garcia-Higuera, B Xu, PR Andreassen, RC Gregory, ST Kim, WS Lane, MB Kastan, AD D'Andrea. Convergence of the Fanconi Anemia and Ataxia Telangiectasia Signaling Pathways. Cell 109:459-72, 2002

160. SI Ahmad, F Hanaoka, SH Kirk. Molecular biology of Fanconi anaemia—an old problem, a new sight. BioEssays 24:439-48, 2002

161. P Pace, M Johnson, WM Tan, G Mosedale, C Sng, M Hoatlin, J de Winter, H Joenje, F Gergely, KJ Patel. FANCE: the link between Fanconi anaemia complex assembly and activity. EMBO J 21:3414-23, 2002

10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook


Post a comment